Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccd4821558f7e9d8b35396a734a1109e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00 |
filingDate |
2004-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc06ea02964146f8f1127f57b0c2e32a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a67691fc6f4754f7035ba41b4043f94 |
publicationDate |
2006-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2473412-A1 |
titleOfInvention |
Liquid pharmaceutical injectable formulation of octreotide |
abstract |
A liquid pharmaceutical composition of pH between about 3 and about 9 comprising (a) octreotide (salt or base) of concentration from about 0.001 to about 5 g/L (under free-peptide form); (b) a suitable inorganic or organic buffer system; (c) in water; (d) in an appropriate container. The packaging material could be treated glass container, or constituted of anoth er appropriate material with or without an elastomeric stopper. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014003199-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104582687-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018211526-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10342850-B2 |
priorityDate |
2004-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |